|
Volumn 14, Issue 8, 2003, Pages 1167-1168
|
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up Ewing's sarcoma of bone
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
VINCRISTINE;
ADOLESCENT;
ADULT;
ARTICLE;
BONE BIOPSY;
BONE MARROW BIOPSY;
BONE METASTASIS;
BONE RADIOGRAPHY;
BONE SCINTISCANNING;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CHROMOSOME TRANSLOCATION 11;
CYTOGENETICS;
EWING SARCOMA;
FOLLOW UP;
HEALTH CARE ORGANIZATION;
HISTOPATHOLOGY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LUNG METASTASIS;
MICROSCOPY;
NEEDLE BIOPSY;
ORTHOPEDIC SURGERY;
POLYMERASE CHAIN REACTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
THORACOTOMY;
TREATMENT PLANNING;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
CHILD;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HEALTH PLANNING GUIDELINES;
HUMANS;
MALE;
NEOPLASM STAGING;
ORTHOPEDIC PROCEDURES;
RADIOTHERAPY, ADJUVANT;
RISK ASSESSMENT;
SARCOMA, EWING'S;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0042885974
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdg335 Document Type: Article |
Times cited : (5)
|
References (5)
|